Institution
University of New South Wales
Education•Sydney, New South Wales, Australia•
About: University of New South Wales is a education organization based out in Sydney, New South Wales, Australia. It is known for research contribution in the topics: Population & Poison control. The organization has 51197 authors who have published 153634 publications receiving 4880608 citations. The organization is also known as: UNSW & UNSW Australia.
Topics: Population, Poison control, Health care, Mental health, Silicon
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The vanadium redox flow battery (VRB) is one of the most promising electrochemical energy storage systems deemed suitable for a wide range of renewable energy applications that are emerging rapidly to reduce the carbon footprint of electricity generation as discussed by the authors.
659 citations
••
Ferdowsi University of Mashhad1, King Mongkut's University of Technology Thonburi2, Xi'an Jiaotong University3, University of Monastir4, Shahid Beheshti University5, University of Rennes6, Clarkson University7, North Carolina State University8, University of Vermont9, Iran University of Science and Technology10, University of New South Wales11, Royal Society12, Quaid-i-Azam University13, King Abdulaziz University14, University of Tehran15, Babeș-Bolyai University16
TL;DR: A review of the latest developments in modeling of nanofluid flows and heat transfer with an emphasis on 3D simulations can be found in this paper, where the main models used to calculate the thermophysical properties of Nanofluids are reviewed.
659 citations
••
TL;DR: In this paper, the authors used parallel factor analysis (PARAFAC) of fluorescence spectra collected on trans-oceanic cruises in the Pacific and Atlantic oceans to investigate the optical characteristics of dissolved organic matter in waters with limited freshwater influence (salinity > 30).
658 citations
••
Harvard University1, University Health Network2, University of Toronto3, Princess Margaret Cancer Centre4, University of New South Wales5, International Agency for Research on Cancer6, Dresden University of Technology7, National Institutes of Health8, Queen's University9, Ghent University10, Ghent University Hospital11, International Atomic Energy Agency12, University of Western Ontario13
TL;DR: The results provide compelling evidence that investment in radiotherapy not only enables treatment of large numbers of cancer cases to save lives, but also brings positive economic benefits.
Abstract: Summary Radiotherapy is a critical and inseparable component of comprehensive cancer treatment and care. For many of the most common cancers in low-income and middle-income countries, radiotherapy is essential for effective treatment. In high-income countries, radiotherapy is used in more than half of all cases of cancer to cure localised disease, palliate symptoms, and control disease in incurable cancers. Yet, in planning and building treatment capacity for cancer, radiotherapy is frequently the last resource to be considered. Consequently, worldwide access to radiotherapy is unacceptably low. We present a new body of evidence that quantifies the worldwide coverage of radiotherapy services by country. We show the shortfall in access to radiotherapy by country and globally for 2015–35 based on current and projected need, and show substantial health and economic benefits to investing in radiotherapy. The cost of scaling up radiotherapy in the nominal model in 2015–35 is US$26·6 billion in low-income countries, $62·6 billion in lower-middle-income countries, and $94·8 billion in upper-middle-income countries, which amounts to $184·0 billion across all low-income and middle-income countries. In the efficiency model the costs were lower: $14·1 billion in low-income, $33·3 billion in lower-middle-income, and $49·4 billion in upper-middle-income countries—a total of $96·8 billion. Scale-up of radiotherapy capacity in 2015–35 from current levels could lead to saving of 26·9 million life-years in low-income and middle-income countries over the lifetime of the patients who received treatment. The economic benefits of investment in radiotherapy are very substantial. Using the nominal cost model could produce a net benefit of $278·1 billion in 2015–35 ($265·2 million in low-income countries, $38·5 billion in lower-middle-income countries, and $239·3 billion in upper-middle-income countries). Investment in the efficiency model would produce in the same period an even greater total benefit of $365·4 billion ($12·8 billion in low-income countries, $67·7 billion in lower-middle-income countries, and $284·7 billion in upper-middle-income countries). The returns, by the human-capital approach, are projected to be less with the nominal cost model, amounting to $16·9 billion in 2015–35 (–$14·9 billion in low-income countries; –$18·7 billion in lower-middle-income countries, and $50·5 billion in upper-middle-income countries). The returns with the efficiency model were projected to be greater, however, amounting to $104·2 billion (–$2·4 billion in low-income countries, $10·7 billion in lower-middle-income countries, and $95·9 billion in upper-middle-income countries). Our results provide compelling evidence that investment in radiotherapy not only enables treatment of large numbers of cancer cases to save lives, but also brings positive economic benefits.
658 citations
••
TL;DR: In this paper, the authors reported the recent improvements in the energy conversion efficiency of solar cells on magnetically-confined Czochralski grown (MCZ) and float zone (FZ) silicon substrates at the University of New South Wales.
Abstract: This paper reports the recent improvements in the energy conversion efficiencies of solar cells on magnetically-confined Czochralski grown (MCZ) and float zone (FZ) silicon substrates at the University of New South Wales. A PERT (passivated emitter, rear totally-diffused) cell structure has been used to reduce the cell series resistance from higher resistivity substrates. The total rear boron diffusion in this PERT structure appears to improve the surface passivation quality of MCZ and some FZ substrates. Hence, higher open-circuit voltages were observed for some PERT cells. One of these cells on MCZ substrates demonstrated 24·5% energy conversion efficiency at Sandia National Laboratories under the standard global spectrum (100 mW/cm2) at 25°C. This is the highest efficiency ever reported for a MCZ silicon solar cell. The cells made on MCZ substrates also showed stable cell performance rather than the usually reported unstable performance for boron-doped CZ substrates. Also reported is a PERL (passivated emitter, rear locally-diffused) cell on a FZ substrate of 24·7% efficiency, which is the highest efficiency ever reported for any silicon solar cell. Copyright © 1999 John Wiley & Sons, Ltd.
657 citations
Authors
Showing all 51897 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ronald C. Kessler | 274 | 1332 | 328983 |
Nicholas G. Martin | 192 | 1770 | 161952 |
John C. Morris | 183 | 1441 | 168413 |
Richard S. Ellis | 169 | 882 | 136011 |
Ian J. Deary | 166 | 1795 | 114161 |
Nicholas J. Talley | 158 | 1571 | 90197 |
Wolfgang Wagner | 156 | 2342 | 123391 |
Bruce D. Walker | 155 | 779 | 86020 |
Xiang Zhang | 154 | 1733 | 117576 |
Ian Smail | 151 | 895 | 83777 |
Rui Zhang | 151 | 2625 | 107917 |
Marvin Johnson | 149 | 1827 | 119520 |
John R. Hodges | 149 | 812 | 82709 |
Amartya Sen | 149 | 689 | 141907 |
J. Fraser Stoddart | 147 | 1239 | 96083 |